Since 1993 we have prospectively identified children with invasive infections caused by S. pneumoniae in the inpatient and outpatient setting at Texas Children's Hospital, Houston, TX. Pneumococci ...

A new study by University of Liverpool researchers reveals how resistance to bacteremic pneumonia is provided by a unique subset of lung T regulatory cells. Streptococcus pneumoniae (the pneumococcus) ...

After the onset of serious pneumococcal infections, patients are at a significantly increased risk of having a heart attack, according to a Vanderbilt study published in the journal Clinical ...

The increase in invasive pneumococcal disease across Europe is driven by Streptococcus pneumoniae, which also causes pneumonia and acute otitis media that can progress to invasive infections. Nearly ...

The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and ...

A new study reveals how resistance to bacteraemic pneumonia is provided by a unique subset of lung T regulatory cells. A new study by University of Liverpool researchers reveals how resistance to ...

In a recent multicenter prospective study conducted at three hospitals in Tennessee and Georgia, including Vanderbilt University Medical Center, researchers at VUMC found a substantial burden of ...

Tuesday, Vaxcyte, Inc. (NASDAQ:PCVX) released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the company's 31-valent pneumococcal conjugate ...

Invasive pneumococcal disease is associated with high morbidity and mortality. The clinical presentation, disease severity, and mortality of pneumococcal infection depends on serotype; serotype 9V is ...

Pneumococcal infections can be very serious – they include pneumonia, meningitis, and bacteremia (a blood infection), as well ...